Sees Q4 revenue $209M-$211M, consensus $212.84M
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYGN:
- Myriad Genetics, MD Anderson forms 5-year strategic alliance
- Myriad Genetics price target lowered to $13 from $15 at BofA
- Myriad Genetics provides an update on engagement with UnitedHealthcare
- Myriad Genetics’ portfolio elevated by updated NCCN prostate cancer guidelines
- Myriad Genetics initiated with a Neutral at UBS
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue